What is Dabt Justine Cunningham email address?

Dabt Justine Cunningham's primary email address is ******************@sana.com. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does Dabt Justine Cunningham work for?

Dabt Justine Cunningham is a VP, Nonclinical Development at REGENXBIO, a company specializing in Commercial physical research.

Where Dabt Justine Cunningham graduated from?

Dabt Justine Cunningham holds a degree in Anatomy (Neuroscience) from The University of Queensland.

How can I directly contact Dabt Justine Cunningham?

To contact Dabt Justine Cunningham directly, you can use the email address ******************@sana.com. Complete contact information is available upon registration with Muraena.

Who is Dabt Justine Cunningham?

Dabt Justine Cunningham is an accomplished pharmacologist and toxicologist with a robust background in the development of innovative biological therapeutics, including gene and stem cell therapies. With extensive expertise in neurosciences, she has contributed to the development of therapies targeting metabolic, ophthalmic, and rare genetic diseases. Justine is skilled in designing in vitro and in vivo assays for non-clinical development, ensuring rigorous safety assessments for first-in-human testing. Her collaborative work spans bioanalytical, pharmacokinetics, and pathology, focusing on exposure and safety evaluations. A seasoned leader, she has held senior roles in various biotech firms, driving key projects from preclinical modeling to regulatory submissions. Justine's educational foundation from The University of Queensland, combined with her diverse experience across multiple organizations, underscores her commitment to advancing therapeutics in the life sciences sector.